Prior to 2013, when the National Cancer Institute released accumulated, de-identified, prostate cancer-specific patient data from the national SEER cancer registry, those data only included the post-surgical, pathological Gleason scores and not the biopsy Gleason scores. Pathological Gleason scores have been captured in the SEER data since 2004. However, in 2010 SEER started to capture […]Image may be NSFW.
Clik here to view.
Clik here to view.
